The impact of alkalization therapy on cancer treatment: a retrospective observational study
Not Applicable
Recruiting
- Conditions
- Patients with cancer
- Registration Number
- JPRN-UMIN000052333
- Lead Sponsor
- Japanese Society on Inflammation and Metabolism in Cancer
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 2000
Inclusion Criteria
Not provided
Exclusion Criteria
1. Those who opt out and do not wish to participate in this study 2. Patients who visited less than two times
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does alkalization therapy modulate tumor microenvironment acidosis to influence cancer progression and treatment outcomes?
What is the comparative effectiveness of alkalization therapy versus standard-of-care treatments in cancer patients?
Which biomarkers correlate with improved survival in cancer patients undergoing alkalization therapy?
What are the potential adverse events associated with long-term alkalization therapy in cancer patients?
How does alkalization therapy synergize with metabolic reprogramming or inflammatory pathway inhibitors in cancer treatment?